James Condulis

Stock Analyst at Stifel

(n/a)

# 4,403

Out of 4,759 analysts

2

Total ratings

n/a

Success rate

-11.26%

Average return

Main Sectors:

Top Industries:

Stocks Rated by James Condulis

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CYTK Cytokinetics	Initiates: Buy	$80	$46.16	+73.31%	1	Jan 22, 2025
	EWTX Edgewise Therapeutics	Initiates: Hold	$30	$25.39	+18.16%	1	Jan 22, 2025

Cytokinetics

Jan 22, 2025

Initiates: Buy

Price Target: $80

Current: $46.16

Upside: +73.31%

Edgewise Therapeutics

Jan 22, 2025

Initiates: Hold

Price Target: $30

Current: $25.39

Upside: +18.16%